Google AI Wizard Jumps to OpenAI

Google's AI wizard Noam Shazeer jumps ship. Leaving Gemini for OpenAI, just as the IPO buzz heats up. Less than two years after Google shelled out billions to reel him back. What's driving this surprise move? And what does it mean for AI's future?

Lilly's new JAK inhibitor just rocked the myelofibrosis world. A 35% spleen shrink in patients. Jakafi might be sweating. Incyte shares dipped over 5%. Could this drug shake up the JAK market and dethrone a $3.1 billion giant? What's next in this pharma showdown?